5 Oversold Healthcare Stocks to Buy
Root, Switzerland-based NovoCure Limited (NASDAQ:NVCR) is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization...
Novocure Ltd (NVCR)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
10 Oversold NASDAQ Stocks to Buy
In this article, we will take a look at the 10 oversold NASDAQ stocks to buy.
5 Worst Performing NASDAQ Stocks In 2023
In this article, we discuss 5 worst performing NASDAQ stocks in 2023.
NovoCure Limited (NASDAQ:NVCR) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
NovoCure Limited (NASDAQ:NVCR) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the NovoCure's Q1 2023 Earnings Conference Call. Please be advised that today’s conference is being recorded.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
NovoCure Limited (NASDAQ:NVCR) Q4 2022 Earnings Call Transcript
Ingrid Goldberg: Good morning, everyone, and thank you for joining us to review Novocure's Fourth Quarter and Full Year 2022 Performance.
5 Biotech Stocks in Billionaire Ray Dalio's Portfolio
In this piece, we will take a look at the 5 biotech stocks in billionaire Ray Dalio's portfolio. If you want more details about Mr.
NovoCure Limited (NVCR) Fell Out Of Favor With Hedge Funds
At Insider Monkey, we pore over the filings of nearly 867 top investment firms every quarter, a process we have now completed for the latest reporting period.
Here is What Hedge Funds Think About NovoCure Limited (NVCR)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
